Silibinin ameliorates depression/anxiety-like behaviors of Parkinson's disease mouse model and is associated with attenuated STING-IRF3-IFN-β pathway activation and neuroinflammation
Xiumin Liu, Wenhui Chen, Chenkang Wang, Weiwei Liu, Toshihiko Hayashi, Kazunori Mizuno, Shunji Hattori, Hitomi Fujisaki, Takashi Ikejima
Topics & Concepts
SilibininTail suspension testPharmacologyNeuroinflammationBehavioural despair testMedicineMPTPElevated plus mazeEndocrinologyInternal medicineHippocampusParkinson's diseaseAnxietyPsychiatryInflammationDiseaseAntidepressantInflammasome and immune disordersinterferon and immune responsesCalcium signaling and nucleotide metabolism